Global and United States Parathyroid Hormone Analog Market Insights, Forecast to 2026

Publisher Name :
Date: 30-Nov-2020
No. of pages: 144
Inquire Before Buying

Parathyroid Hormone Analog market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Parathyroid Hormone Analog market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Parathyroid Hormone Analog market is segmented into

- Abaloparatide

- Teriparatide

- Human Parathyroid Hormone Recombinant

Segment by Application, the Parathyroid Hormone Analog market is segmented into

- Hospitals

- Clinics

- Other

Regional and Country-level Analysis

The Parathyroid Hormone Analog market is analysed and market size information is provided by regions (countries).

The key regions covered in the Parathyroid Hormone Analog market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Parathyroid Hormone Analog Market Share Analysis

Parathyroid Hormone Analog market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parathyroid Hormone Analog business, the date to enter into the Parathyroid Hormone Analog market, Parathyroid Hormone Analog product introduction, recent developments, etc.

The major vendors covered:

- Pfizer

- Abbott Laboratories

- Merck

- Natpara

- GlaxoSmithKline Plc

- Sanofi SA

- Eli Lilly

- Cell Genesys Inc

- OSI Pharmaceuticals

- Paladin Labs Inc

- ALZA Corporation

Global and United States Parathyroid Hormone Analog Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Parathyroid Hormone Analog Product Introduction
1.2 Market Segments
1.3 Key Parathyroid Hormone Analog Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Parathyroid Hormone Analog Market Size Growth Rate by Type
1.4.2 Abaloparatide
1.4.3 Teriparatide
1.4.4 Human Parathyroid Hormone Recombinant
1.5 Market by Application
1.5.1 Global Parathyroid Hormone Analog Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parathyroid Hormone Analog Market Size, Estimates and Forecasts
2.1.1 Global Parathyroid Hormone Analog Revenue 2015-2026
2.1.2 Global Parathyroid Hormone Analog Sales 2015-2026
2.2 Global Parathyroid Hormone Analog, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Parathyroid Hormone Analog Historical Market Size by Region (2015-2020)
2.3.1 Global Parathyroid Hormone Analog Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Parathyroid Hormone Analog Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Parathyroid Hormone Analog Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Parathyroid Hormone Analog Sales Forecast by Region (2021-2026)
2.4.2 Global Parathyroid Hormone Analog Revenue Forecast by Region (2021-2026)
3 Global Parathyroid Hormone Analog Competitor Landscape by Players
3.1 Global Top Parathyroid Hormone Analog Sales by Manufacturers
3.1.1 Global Parathyroid Hormone Analog Sales by Manufacturers (2015-2020)
3.1.2 Global Parathyroid Hormone Analog Sales Market Share by Manufacturers (2015-2020)
3.2 Global Parathyroid Hormone Analog Manufacturers by Revenue
3.2.1 Global Parathyroid Hormone Analog Revenue by Manufacturers (2015-2020)
3.2.2 Global Parathyroid Hormone Analog Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Parathyroid Hormone Analog Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Parathyroid Hormone Analog Revenue in 2019
3.2.5 Global Parathyroid Hormone Analog Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Parathyroid Hormone Analog Price by Manufacturers
3.4 Global Parathyroid Hormone Analog Manufacturing Base Distribution, Product Types
3.4.1 Parathyroid Hormone Analog Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parathyroid Hormone Analog Product Type
3.4.3 Date of International Manufacturers Enter into Parathyroid Hormone Analog Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parathyroid Hormone Analog Market Size by Type (2015-2020)
4.1.1 Global Parathyroid Hormone Analog Sales by Type (2015-2020)
4.1.2 Global Parathyroid Hormone Analog Revenue by Type (2015-2020)
4.1.3 Parathyroid Hormone Analog Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Parathyroid Hormone Analog Market Size Forecast by Type (2021-2026)
4.2.1 Global Parathyroid Hormone Analog Sales Forecast by Type (2021-2026)
4.2.2 Global Parathyroid Hormone Analog Revenue Forecast by Type (2021-2026)
4.2.3 Parathyroid Hormone Analog Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Parathyroid Hormone Analog Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Parathyroid Hormone Analog Market Size by Application (2015-2020)
5.1.1 Global Parathyroid Hormone Analog Sales by Application (2015-2020)
5.1.2 Global Parathyroid Hormone Analog Revenue by Application (2015-2020)
5.1.3 Parathyroid Hormone Analog Price by Application (2015-2020)
5.2 Parathyroid Hormone Analog Market Size Forecast by Application (2021-2026)
5.2.1 Global Parathyroid Hormone Analog Sales Forecast by Application (2021-2026)
5.2.2 Global Parathyroid Hormone Analog Revenue Forecast by Application (2021-2026)
5.2.3 Global Parathyroid Hormone Analog Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
6.1.1 United States Parathyroid Hormone Analog Sales YoY Growth 2015-2026
6.1.2 United States Parathyroid Hormone Analog Revenue YoY Growth 2015-2026
6.1.3 United States Parathyroid Hormone Analog Market Share in Global Market 2015-2026
6.2 United States Parathyroid Hormone Analog Market Size by Players (International and Local Players)
6.2.1 United States Top Parathyroid Hormone Analog Players by Sales (2015-2020)
6.2.2 United States Top Parathyroid Hormone Analog Players by Revenue (2015-2020)
6.3 United States Parathyroid Hormone Analog Historic Market Review by Type (2015-2020)
6.3.1 United States Parathyroid Hormone Analog Sales Market Share by Type (2015-2020)
6.3.2 United States Parathyroid Hormone Analog Revenue Market Share by Type (2015-2020)
6.3.3 United States Parathyroid Hormone Analog Price by Type (2015-2020)
6.4 United States Parathyroid Hormone Analog Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Parathyroid Hormone Analog Sales Forecast by Type (2021-2026)
6.4.2 United States Parathyroid Hormone Analog Revenue Forecast by Type (2021-2026)
6.4.3 United States Parathyroid Hormone Analog Price Forecast by Type (2021-2026)
6.5 United States Parathyroid Hormone Analog Historic Market Review by Application (2015-2020)
6.5.1 United States Parathyroid Hormone Analog Sales Market Share by Application (2015-2020)
6.5.2 United States Parathyroid Hormone Analog Revenue Market Share by Application (2015-2020)
6.5.3 United States Parathyroid Hormone Analog Price by Application (2015-2020)
6.6 United States Parathyroid Hormone Analog Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Parathyroid Hormone Analog Sales Forecast by Application (2021-2026)
6.6.2 United States Parathyroid Hormone Analog Revenue Forecast by Application (2021-2026)
6.6.3 United States Parathyroid Hormone Analog Price Forecast by Application (2021-2026)
7 North America
7.1 North America Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
7.2 North America Parathyroid Hormone Analog Market Facts & Figures by Country
7.2.1 North America Parathyroid Hormone Analog Sales by Country (2015-2020)
7.2.2 North America Parathyroid Hormone Analog Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
8.2 Europe Parathyroid Hormone Analog Market Facts & Figures by Country
8.2.1 Europe Parathyroid Hormone Analog Sales by Country
8.2.2 Europe Parathyroid Hormone Analog Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
9.2 Asia Pacific Parathyroid Hormone Analog Market Facts & Figures by Country
9.2.1 Asia Pacific Parathyroid Hormone Analog Sales by Region (2015-2020)
9.2.2 Asia Pacific Parathyroid Hormone Analog Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
10.2 Latin America Parathyroid Hormone Analog Market Facts & Figures by Country
10.2.1 Latin America Parathyroid Hormone Analog Sales by Country
10.2.2 Latin America Parathyroid Hormone Analog Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Parathyroid Hormone Analog Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Parathyroid Hormone Analog Market Facts & Figures by Country
11.2.1 Middle East and Africa Parathyroid Hormone Analog Sales by Country
11.2.2 Middle East and Africa Parathyroid Hormone Analog Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Parathyroid Hormone Analog Products Offered
12.1.5 Pfizer Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Corporation Information
12.2.2 Abbott Laboratories Description and Business Overview
12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories Parathyroid Hormone Analog Products Offered
12.2.5 Abbott Laboratories Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Parathyroid Hormone Analog Products Offered
12.3.5 Merck Recent Development
12.4 Natpara
12.4.1 Natpara Corporation Information
12.4.2 Natpara Description and Business Overview
12.4.3 Natpara Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Natpara Parathyroid Hormone Analog Products Offered
12.4.5 Natpara Recent Development
12.5 GlaxoSmithKline Plc
12.5.1 GlaxoSmithKline Plc Corporation Information
12.5.2 GlaxoSmithKline Plc Description and Business Overview
12.5.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Plc Parathyroid Hormone Analog Products Offered
12.5.5 GlaxoSmithKline Plc Recent Development
12.6 Sanofi SA
12.6.1 Sanofi SA Corporation Information
12.6.2 Sanofi SA Description and Business Overview
12.6.3 Sanofi SA Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi SA Parathyroid Hormone Analog Products Offered
12.6.5 Sanofi SA Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Corporation Information
12.7.2 Eli Lilly Description and Business Overview
12.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Eli Lilly Parathyroid Hormone Analog Products Offered
12.7.5 Eli Lilly Recent Development
12.8 Cell Genesys Inc
12.8.1 Cell Genesys Inc Corporation Information
12.8.2 Cell Genesys Inc Description and Business Overview
12.8.3 Cell Genesys Inc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cell Genesys Inc Parathyroid Hormone Analog Products Offered
12.8.5 Cell Genesys Inc Recent Development
12.9 OSI Pharmaceuticals
12.9.1 OSI Pharmaceuticals Corporation Information
12.9.2 OSI Pharmaceuticals Description and Business Overview
12.9.3 OSI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 OSI Pharmaceuticals Parathyroid Hormone Analog Products Offered
12.9.5 OSI Pharmaceuticals Recent Development
12.10 Paladin Labs Inc
12.10.1 Paladin Labs Inc Corporation Information
12.10.2 Paladin Labs Inc Description and Business Overview
12.10.3 Paladin Labs Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Paladin Labs Inc Parathyroid Hormone Analog Products Offered
12.10.5 Paladin Labs Inc Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Parathyroid Hormone Analog Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Parathyroid Hormone Analog Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parathyroid Hormone Analog Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Parathyroid Hormone Analog Market Segments
Table 2. Ranking of Global Top Parathyroid Hormone Analog Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Parathyroid Hormone Analog Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Abaloparatide
Table 5. Major Manufacturers of Teriparatide
Table 6. Major Manufacturers of Human Parathyroid Hormone Recombinant
Table 7. Global Parathyroid Hormone Analog Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Parathyroid Hormone Analog Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Parathyroid Hormone Analog Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Parathyroid Hormone Analog Sales Market Share by Regions (2015-2020)
Table 11. Global Parathyroid Hormone Analog Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Parathyroid Hormone Analog Sales Forecast by Region (2021-2026) (K Pcs)
Table 13. Global Parathyroid Hormone Analog Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Parathyroid Hormone Analog Sales Share by Manufacturers (2015-2020)
Table 15. Global Parathyroid Hormone Analog Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Parathyroid Hormone Analog by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parathyroid Hormone Analog as of 2019)
Table 17. Parathyroid Hormone Analog Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Parathyroid Hormone Analog Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Parathyroid Hormone Analog Price (2015-2020) (USD/Pcs)
Table 20. Parathyroid Hormone Analog Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Parathyroid Hormone Analog Product Type
Table 22. Date of International Manufacturers Enter into Parathyroid Hormone Analog Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Parathyroid Hormone Analog Sales by Type (2015-2020) (K Pcs)
Table 25. Global Parathyroid Hormone Analog Sales Share by Type (2015-2020)
Table 26. Global Parathyroid Hormone Analog Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Parathyroid Hormone Analog Revenue Share by Type (2015-2020)
Table 28. Parathyroid Hormone Analog Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Parathyroid Hormone Analog Sales Share by Type (2021-2026)
Table 30. Global Parathyroid Hormone Analog Sales by Application (2015-2020) (K Pcs)
Table 31. Global Parathyroid Hormone Analog Sales Share by Application (2015-2020)
Table 32. Global Parathyroid Hormone Analog Sales Share by Application (2021-2026)
Table 33. Global Parathyroid Hormone Analog Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Parathyroid Hormone Analog Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Parathyroid Hormone Analog Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Parathyroid Hormone Analog Sales (K Pcs) of Key Companies (2015-2020)
Table 37. United States Parathyroid Hormone Analog Sales Share by Company (2015-2020)
Table 38. United States Parathyroid Hormone Analog Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Parathyroid Hormone Analog Sales (K Pcs) by Type (2015-2020)
Table 40. United States Parathyroid Hormone Analog Sales Share by Type (2015-2020)
Table 41. United States Parathyroid Hormone Analog Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Parathyroid Hormone Analog Price (K Pcs) by Type (2015-2020)
Table 43. United States Parathyroid Hormone Analog Sales (K Pcs) by Type (2021-2026)
Table 44. United States Parathyroid Hormone Analog Sales Share by Type (2021-2026)
Table 45. United States Parathyroid Hormone Analog Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Parathyroid Hormone Analog Revenue Share by Type (2021-2026)
Table 47. United States Parathyroid Hormone Analog Price (K Pcs) by Type (2021-2026)
Table 48. United States Parathyroid Hormone Analog Sales (K Pcs) by Application (2015-2020)
Table 49. United States Parathyroid Hormone Analog Sales Share by Application (2015-2020)
Table 50. United States Parathyroid Hormone Analog Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Parathyroid Hormone Analog Sales (K Pcs) by Application (2021-2026)
Table 52. United States Parathyroid Hormone Analog Sales Share by Application (2021-2026)
Table 53. United States Parathyroid Hormone Analog Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Parathyroid Hormone Analog Revenue Share by Application (2021-2026)
Table 55. North America Parathyroid Hormone Analog Sales by Country (2015-2020) (K Pcs)
Table 56. North America Parathyroid Hormone Analog Sales Market Share by Country (2015-2020)
Table 57. North America Parathyroid Hormone Analog Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Parathyroid Hormone Analog Revenue Market Share by Country (2015-2020)
Table 59. Europe Parathyroid Hormone Analog Sales by Country (2015-2020) (K Pcs)
Table 60. Europe Parathyroid Hormone Analog Sales Market Share by Country (2015-2020)
Table 61. Europe Parathyroid Hormone Analog Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Parathyroid Hormone Analog Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Parathyroid Hormone Analog Sales by Region (2015-2020) (K Pcs)
Table 64. Asia Pacific Parathyroid Hormone Analog Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Parathyroid Hormone Analog Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Parathyroid Hormone Analog Revenue Market Share by Region (2015-2020)
Table 67. Latin America Parathyroid Hormone Analog Sales by Country (2015-2020) (K Pcs)
Table 68. Latin America Parathyroid Hormone Analog Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Parathyroid Hormone Analog Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Parathyroid Hormone Analog Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Parathyroid Hormone Analog Sales by Country (2015-2020) (K Pcs)
Table 72. Middle East and Africa Parathyroid Hormone Analog Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Parathyroid Hormone Analog Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Parathyroid Hormone Analog Revenue Market Share by Country (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Pfizer Parathyroid Hormone Analog Product
Table 79. Pfizer Recent Development
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Natpara Corporation Information
Table 91. Natpara Description and Business Overview
Table 92. Natpara Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Natpara Product
Table 94. Natpara Recent Development
Table 95. GlaxoSmithKline Plc Corporation Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Plc Product
Table 99. GlaxoSmithKline Plc Recent Development
Table 100. Sanofi SA Corporation Information
Table 101. Sanofi SA Description and Business Overview
Table 102. Sanofi SA Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Sanofi SA Product
Table 104. Sanofi SA Recent Development
Table 105. Eli Lilly Corporation Information
Table 106. Eli Lilly Description and Business Overview
Table 107. Eli Lilly Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Eli Lilly Product
Table 109. Eli Lilly Recent Development
Table 110. Cell Genesys Inc Corporation Information
Table 111. Cell Genesys Inc Description and Business Overview
Table 112. Cell Genesys Inc Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Cell Genesys Inc Product
Table 114. Cell Genesys Inc Recent Development
Table 115. OSI Pharmaceuticals Corporation Information
Table 116. OSI Pharmaceuticals Description and Business Overview
Table 117. OSI Pharmaceuticals Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. OSI Pharmaceuticals Product
Table 119. OSI Pharmaceuticals Recent Development
Table 120. Paladin Labs Inc Corporation Information
Table 121. Paladin Labs Inc Description and Business Overview
Table 122. Paladin Labs Inc Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Paladin Labs Inc Product
Table 124. Paladin Labs Inc Recent Development
Table 125. ALZA Corporation Corporation Information
Table 126. ALZA Corporation Description and Business Overview
Table 127. ALZA Corporation Parathyroid Hormone Analog Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. ALZA Corporation Product
Table 129. ALZA Corporation Recent Development
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Parathyroid Hormone Analog Players
Table 134. Parathyroid Hormone Analog Customers List
Table 135. Parathyroid Hormone Analog Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Parathyroid Hormone Analog Product Picture
Figure 2. Global Parathyroid Hormone Analog Sales Market Share by Type in 2020 & 2026
Figure 3. Abaloparatide Product Picture
Figure 4. Teriparatide Product Picture
Figure 5. Human Parathyroid Hormone Recombinant Product Picture
Figure 6. Global Parathyroid Hormone Analog Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Other
Figure 10. Parathyroid Hormone Analog Report Years Considered
Figure 11. Global Parathyroid Hormone Analog Market Size 2015-2026 (US$ Million)
Figure 12. Global Parathyroid Hormone Analog Sales 2015-2026 (K Pcs)
Figure 13. Global Parathyroid Hormone Analog Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Parathyroid Hormone Analog Sales Market Share by Region (2015-2020)
Figure 15. Global Parathyroid Hormone Analog Sales Market Share by Region in 2019
Figure 16. Global Parathyroid Hormone Analog Revenue Market Share by Region (2015-2020)
Figure 17. Global Parathyroid Hormone Analog Revenue Market Share by Region in 2019
Figure 18. Global Parathyroid Hormone Analog Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Parathyroid Hormone Analog Revenue in 2019
Figure 20. Parathyroid Hormone Analog Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Parathyroid Hormone Analog Sales Market Share by Type (2015-2020)
Figure 22. Global Parathyroid Hormone Analog Sales Market Share by Type in 2019
Figure 23. Global Parathyroid Hormone Analog Revenue Market Share by Type (2015-2020)
Figure 24. Global Parathyroid Hormone Analog Revenue Market Share by Type in 2019
Figure 25. Global Parathyroid Hormone Analog Market Share by Price Range (2015-2020)
Figure 26. Global Parathyroid Hormone Analog Sales Market Share by Application (2015-2020)
Figure 27. Global Parathyroid Hormone Analog Sales Market Share by Application in 2019
Figure 28. Global Parathyroid Hormone Analog Revenue Market Share by Application (2015-2020)
Figure 29. Global Parathyroid Hormone Analog Revenue Market Share by Application in 2019
Figure 30. United States Parathyroid Hormone Analog Sales Growth Rate 2015-2026 (K Pcs)
Figure 31. United States Parathyroid Hormone Analog Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. United States Parathyroid Hormone Analog Market Share in Global Market 2015-2026
Figure 33. United States 5 and 10 Largest Parathyroid Hormone Analog Players Market Share by Revenue in Parathyroid Hormone Analog in 2019
Figure 34. United States Parathyroid Hormone Analog Revenue Share by Type (2015-2020)
Figure 35. United States Parathyroid Hormone Analog Revenue Growth Rate by Type in 2015 & 2019
Figure 36. United States Parathyroid Hormone Analog Revenue Share by Application (2015-2020)
Figure 37. United States Parathyroid Hormone Analog Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Parathyroid Hormone Analog Sales Growth Rate 2015-2020 (K Pcs)
Figure 39. North America Parathyroid Hormone Analog Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Parathyroid Hormone Analog Sales Market Share by Country in 2019
Figure 41. North America Parathyroid Hormone Analog Revenue Market Share by Country in 2019
Figure 42. U.S. Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. U.S. Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Canada Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Parathyroid Hormone Analog Sales Growth Rate 2015-2020 (K Pcs)
Figure 47. Europe Parathyroid Hormone Analog Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Parathyroid Hormone Analog Sales Market Share by Country in 2019
Figure 49. Europe Parathyroid Hormone Analog Revenue Market Share by Country in 2019
Figure 50. Germany Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Germany Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. France Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.K. Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Italy Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Parathyroid Hormone Analog Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Parathyroid Hormone Analog Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Parathyroid Hormone Analog Sales Market Share by Region in 2019
Figure 63. Asia Pacific Parathyroid Hormone Analog Revenue Market Share by Region in 2019
Figure 64. China Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Parathyroid Hormone Analog Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Parathyroid Hormone Analog Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Parathyroid Hormone Analog Sales Market Share by Country in 2019
Figure 89. Latin America Parathyroid Hormone Analog Revenue Market Share by Country in 2019
Figure 90. Mexico Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Parathyroid Hormone Analog Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Parathyroid Hormone Analog Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Parathyroid Hormone Analog Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Parathyroid Hormone Analog Revenue Market Share by Country in 2019
Figure 100. Turkey Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Parathyroid Hormone Analog Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Parathyroid Hormone Analog Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Parathyroid Hormone Analog Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs